↓ Skip to main content

Dove Medical Press

Efficacy and safety of a herbal mixture (Viron® tablets) in the treatment of patients with chronic hepatitis C virus infection: a prospective, randomized, open-label, proof-of-concept study

Overview of attention for article published in Drug Design, Development and Therapy, February 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

googleplus
1 Google+ user
video
1 YouTube creator

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
49 Mendeley
Title
Efficacy and safety of a herbal mixture (Viron® tablets) in the treatment of patients with chronic hepatitis C virus infection: a prospective, randomized, open-label, proof-of-concept study
Published in
Drug Design, Development and Therapy, February 2015
DOI 10.2147/dddt.s77168
Pubmed ID
Authors

Hisham Shawkat, Mostafa Yakoot, Tarek Shawkat, Sherine Helmy

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 18%
Student > Doctoral Student 6 12%
Researcher 6 12%
Student > Bachelor 5 10%
Unspecified 3 6%
Other 8 16%
Unknown 12 24%
Readers by discipline Count As %
Medicine and Dentistry 16 33%
Unspecified 3 6%
Biochemistry, Genetics and Molecular Biology 3 6%
Nursing and Health Professions 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Other 8 16%
Unknown 13 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2015.
All research outputs
#16,722,190
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#1,011
of 2,268 outputs
Outputs of similar age
#211,880
of 361,178 outputs
Outputs of similar age from Drug Design, Development and Therapy
#31
of 62 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,178 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.